Traws Pharma, Inc.: depreciation, depletion and amortization

What this measure means

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Exact concept: us-gaap:DepreciationDepletionAndAmortization. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2011-01-01 to 2025-12-31. The SEC response was captured on 2026-09-20.

Selected filing history

Related financial histories

• Traws Pharma, Inc.: total assets
• Traws Pharma, Inc.: total liabilities
• Traws Pharma, Inc.: stockholders equity
• Traws Pharma, Inc.: cash and cash equivalents
• Traws Pharma, Inc.: net income or loss
• Traws Pharma, Inc.: operating cash flow
• Traws Pharma, Inc.: capital expenditure payments
• Traws Pharma, Inc.: revenue
• Traws Pharma, Inc.: financing cash flow
• Traws Pharma, Inc.: investing cash flow
• Traws Pharma, Inc.: retained earnings or deficit
• Traws Pharma, Inc.: basic weighted-average shares
• Traws Pharma, Inc.: diluted weighted-average shares
• Traws Pharma, Inc.: basic earnings per share
• Traws Pharma, Inc.: diluted earnings per share
• Traws Pharma, Inc.: income tax expense or benefit
• Traws Pharma, Inc.: net property, plant and equipment
• Traws Pharma, Inc.: share-based compensation expense
• Traws Pharma, Inc.: operating income or loss
• Traws Pharma, Inc.: current assets
• Traws Pharma, Inc.: interest expense
• Traws Pharma, Inc.: current liabilities
• Traws Pharma, Inc.: current accounts payable
• Traws Pharma, Inc.: operating expenses
• Traws Pharma, Inc.: research and development expense
• Traws Pharma, Inc.: common shares outstanding
• Traws Pharma, Inc.: cash including restricted cash
• Traws Pharma, Inc.: accumulated other comprehensive income or loss
• Traws Pharma, Inc.: total equity including noncontrolling interests
• Traws Pharma, Inc.: gross property, plant and equipment
• Traws Pharma, Inc.: accumulated depreciation on property, plant and equipment
• Traws Pharma, Inc.: other noncurrent assets
• Traws Pharma, Inc.: other noncurrent liabilities
• Traws Pharma, Inc.: accrued current liabilities
• Traws Pharma, Inc.: prepaid expenses and other current assets
• Traws Pharma, Inc.: current contract liabilities
• Traws Pharma, Inc.: net deferred tax assets
• Traws Pharma, Inc.: pre-tax income or loss from continuing operations
• Traws Pharma, Inc.: profit or loss including noncontrolling interests
• Traws Pharma, Inc.: comprehensive income or loss
• Traws Pharma, Inc.: net income available to common stockholders
• Traws Pharma, Inc.: general and administrative expense
• Traws Pharma, Inc.: other nonoperating income or expense
• Traws Pharma, Inc.: current income tax expense or benefit
• Traws Pharma, Inc.: deferred income tax expense or benefit
• Traws Pharma, Inc.: proceeds from issuing common stock
• Traws Pharma, Inc.: change in accounts payable

Inspect the source

Entity

Traws Pharma, Inc. / CIK 0001130598

Captured

2026-09-20T07:40:57.694Z

SEC response SHA-256

c7aad4bae6948c123e86432faae3c4936a66036b64d2dcc75cc144be1c1002e5

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001130598.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))